🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Filippo de Braud

University of Milan

ORCID: 0000-0003-0103-730X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.452Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Papers

Driven by 11 papers — median percentile 58. Top paper: “Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial”.

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30321-1
N/A
5.7DataRank · unranked
527 citations

Ulrik Lassen, Élena Elez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle +14 more

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-MutantKRASWild-Type Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad007
N/A
1.2DataRank · unranked
53 citations

Eric Van Cutsem, Elena Garralda, David Tai, Filippo de Braud, Ravit Geva +9 more

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Hepatology(2023)10.1097/hep.0000000000000365
N/A
0.590DataRank · unranked
50 citations

Milind M. Javle, Helena Verdaguer Mata, Filippo de Braud, Jörg Trojan, Jean-Luc Raoul +15 more

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers

Nature Communications(2020)10.1038/s41467-020-16243-3
N/A
0DataRank · unranked
156 citations

Franca Raucci, Claudio Vernieri, Irene Caffa, Roberta Buono, Maura Fanti +6 more

Ascites During Selpercatinib Treatment: Need for a Multidisciplinary Approach

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2022.09.229
N/A
0DataRank · unranked
3 citations

Silvia Damian, Matteo Duca, S. Della Valle, Filippo de Braud, Leonardo Provenzano

Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records

medRxiv(2025)10.1101/2025.10.16.25337917
N/A
0DataRank · unranked
0 citations

V. Peppoloni, Laura Mazzeo, Giuseppe Leone, Luana Passos, V. Miskovic +39 more

1470P Transcriptomic signature and immune infiltrate in metastatic collecting duct renal cell carcinoma patients treated with first-line cabozantinib: Results of exploratory endpoints from BONSAI trial (Meeturo 2)

Annals of Oncology(2022)10.1016/j.annonc.2022.07.1573
N/A
0DataRank · unranked
0 citations

Katia Todoerti, L. Rivoltini, Veronica Huber, Monica Rodolfo, Luca Agnelli +13 more

Fasting-mimicking diet and hormone therapy induce breast cancer regression

Nature(2020)10.1038/s41586-020-2502-7
N/A
0DataRank · unranked
362 citations

V. Spagnolo, Claudio Vernieri, Francesca Valdemarin, Pamela Becherini, Min Wei +29 more

540P Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.08.654
N/A
0DataRank · unranked
1 citations

Filippo de Braud, Alexander Drilon, Robert C. Doebele, Manish R. Patel, Byoung Chul Cho +15 more

EGFRAmplification in Metastatic Colorectal Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab069
N/A
0DataRank · unranked
33 citations

Rona Yaeger, Jaclyn F. Hechtman, Paolo Manca, Giovanni Fucà, Henry Walch +21 more